Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

461 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Balancing the Risk of Bleeding and Stroke in Patients With Atrial Fibrillation After Percutaneous Coronary Intervention (from the AVIATOR Registry).
Mennuni MG, Halperin JL, Bansilal S, Schoos MM, Theodoropoulos KN, Meelu OA, Sartori S, Giacoppo D, Bernelli C, Moreno PR, Krishnan P, Baber U, Lucarelli C, Dangas GD, Sharma SK, Kini AS, Tamburino C, Chieffo A, Colombo A, Presbitero P, Mehran R. Mennuni MG, et al. Among authors: halperin jl. Am J Cardiol. 2015 Jul 1;116(1):37-42. doi: 10.1016/j.amjcard.2015.03.033. Epub 2015 Apr 8. Am J Cardiol. 2015. PMID: 25956624
Pathophysiologic correlates of thromboembolism in nonvalvular atrial fibrillation: I. Reduced flow velocity in the left atrial appendage (The Stroke Prevention in Atrial Fibrillation [SPAF-III] study).
Goldman ME, Pearce LA, Hart RG, Zabalgoitia M, Asinger RW, Safford R, Halperin JL. Goldman ME, et al. Among authors: halperin jl. J Am Soc Echocardiogr. 1999 Dec;12(12):1080-7. doi: 10.1016/s0894-7317(99)70105-7. J Am Soc Echocardiogr. 1999. PMID: 10588784 Clinical Trial.
Ximelagatran compared with warfarin for prevention of thromboembolism in patients with nonvalvular atrial fibrillation: Rationale, objectives, and design of a pair of clinical studies and baseline patient characteristics (SPORTIF III and V).
Halperin JL; Executive Steering Committee, SPORTIF III and V Study Investigators. Halperin JL, et al. Am Heart J. 2003 Sep;146(3):431-8. doi: 10.1016/S0002-8703(03)00325-9. Am Heart J. 2003. PMID: 12947359 Clinical Trial.
461 results